Vitrolife
158
SEK
+3,61 %
Mindre end 1K følgere
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+3,61%
-7,22%
-25,19%
-26,51%
-32,82%
-2,53%
-36,8%
-11,73%
+2.474,55%
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Læs mereMarkedsværdi
21,4 mia. SEK
Aktieomsætning
14,97 mio. SEK
Omsætning
3,61 mia.
EBIT %
21,7 %
P/E
41,69
Udbytteafkast, %
0,7 %
Finanskalender
24.4
2025
Delårsrapport Q1'25
29.4
2025
Generalforsamling '25
30.4
2025
Årligt udbytte
Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Vitrolife AB (publ): Conference call interim report
Vitrolife AB (publ): The Vitrolife Group introduces changes to the executive management team and strengthens focus on innovation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools